Analyzing the expression levels of the gene CDK9 (cyclin dependent kinase) and its attached molecule CYCLIN T1 in lymphoid cells in a sample of blood can accurately pinpoint lymphoma, according to researchers at Temple University’s Sbarro Institute for Cancer Research and Molecular Medicine (http://www.shro.org) and the Department of Human Pathology and Oncology at the University of Siena in Italy. Their study, “CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation,” appears in the Journal of Pathology (Volume 203, Issue 4).
